Deutsch & Kellner Group Maintain Significant AIM ImmunoTech Stake

TL;DR

**Todd Deutsch still owns 1.7M shares of AIM ImmunoTech, keeping a close eye on the company.**

AI Summary

Todd Deutsch and Ted D. Kellner, as a group, have filed an Amendment No. 3 to their Schedule 13D for AIM ImmunoTech Inc. (AIM). As of January 3, 2024, Todd Deutsch beneficially owns 1,716,100 shares of AIM's common stock, representing a significant stake. This filing indicates a continued active interest and potential influence by these individuals, which matters to shareholders as their actions could impact company strategy or future stock performance.

Why It Matters

This filing shows that a notable investor group continues to hold a substantial position in AIM ImmunoTech, signaling their ongoing commitment or strategic interest in the company.

Risk Assessment

Risk Level: low — This filing is an amendment, indicating a stable, ongoing position rather than a new, volatile event.

Analyst Insight

Investors should monitor future filings from Todd Deutsch and Ted D. Kellner for any changes in their beneficial ownership, as a significant increase or decrease could signal a shift in their outlook on AIM ImmunoTech Inc.

Key Numbers

• 1,716,100 — Shares Beneficially Owned (Represents the sole voting and dispositive power of Todd Deutsch in AIM ImmunoTech Inc.)
• $0.001 — Par Value per Share (The stated par value of AIM ImmunoTech Inc. Common Stock.)

Key Players & Entities

• Todd Deutsch (person) — Reporting Person, beneficial owner of 1,716,100 shares
• Ted D. Kellner (person) — Member of the reporting group
• AIM ImmunoTech Inc. (company) — The Issuer of the securities
• 1,716,100 (dollar_amount) — Number of shares beneficially owned by Todd Deutsch
• January 3, 2024 (date) — Date of event requiring the filing

Forward-Looking Statements

• Todd Deutsch and Ted D. Kellner will maintain their significant stake in AIM ImmunoTech Inc. for the foreseeable future. (Todd Deutsch) — medium confidence, target: 2025-01-03
• The reporting group may seek to influence strategic decisions at AIM ImmunoTech Inc. given their substantial ownership. (AIM ImmunoTech Inc.) — medium confidence, target: 2024-12-31

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $0.50 — days: 37,298 shares of Common Stock at $0.50 per share on December 26, 2023; and 12,

Filing Documents

• d874197dsc13da.htm (SC 13D/A) — 46KB
• d874197dex991.htm (EX-99.1) — 8KB
• d874197dex992.htm (EX-99.2) — 7KB
• 0001193125-24-001518.txt ( ) — 62KB

Purpose of the Transaction

Item 4. Purpose of the Transaction

is hereby

Item 4 is hereby supplemented as follows: On December 28, 2023, the Delaware Court of Chancery ruled in Mr. Kellners favor that four separate advance notice bylaw provisions adopted by the Companys Board of Directors in March 2023 are invalid. However, despite this ruling, the Court went on to find that Mr. Kellners notice of nominations did not comply with certain of the Companys remaining (or predecessor) advance notice provisions. The Reporting Persons disagree with the Courts opinion on this latter finding as to numerous matters of fact and law and Mr. Kellner is seeking an expedited appeal and to enjoin the Companys Annual Meeting pending such appeal. The Reporting Persons are attaching as exhibit hereto a copy of a press release that the Kellner Group issued on January 3, 2024 with respect to the foregoing. The Reporting Persons do not intend in the near term to acquire additional shares of Common Stock or dispose of the shares of Common Stock they currently hold. However, the Reporting Persons will review their investments in the Company on a continuing basis and may in the future determine (1) to acquire additional securities of the Company (although they reiterate that it is not their intention, either alone or acting together with any other persons or group of persons, to acquire a control stake in the shares of Common Stock), (2) to dispose of all or a portion of the securities of the Company owned by them or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intention with respect to any or all of such matters. In reaching any decision as to its course of action (as well as to the specific elements thereof), the Reporting Persons currently expect that they would take into consideration a variety of factors, including, but not limited to, the following: the actions of the Companys board and whether the Reporting Persons believe it is acting

is hereby supplemented as follows

Item 5 is hereby supplemented as follows: (a) Following the transactions described under (c) below, Mr. Kellner is the beneficial owner of 1,493,000 shares of Common Stock, or 3.1% of the Companys outstanding shares. The Group consisting of Mr. Deutsch and Mr. Kellner owns an aggregate of 3,209,100 shares of Common Stock, or 6.6% of the Companys outstanding shares. The ownership percentages above are based on 48,841,656 shares of Common Stock outstanding as reported in the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2023. (b) Following the transactions described under (c) below, Mr. Kellner has sole voting and dispositive power over 394,000 shares of Common Stock and shared voting and dispositive power over 1,099,000 shares of Common Stock with his wife, Mary T, Kellner. (c) Mr. Kellner acquired the following shares of Common Stock in open market purchases in the last 60 days: 37,298 shares of Common Stock at $0.50 per share on December 26, 2023; and 12,702 shares of Common Stock at $0.50 per share on December 27, 2023.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

is hereby supplemented as follows

Item 6 is hereby supplemented as follows: The Group Agreement entered into by the Reporting Persons and Mr. Chioini on July 26, 2023 automatically expires by its terms at the completion of the Companys Annual Meeting. On January 3, 2024, the parties amended the Group Agreement so that it does not automatically expire at the completion of the Companys Annual Meeting, which is currently scheduled to be reconvened on January 5, 2024 absent an injunction pending Mr. Kellners appeal. A copy of the Amendment to the Group Agreement is attached as an exhibit hereto.

Material to be Filed as Exhibits

Item 7. Material to be Filed as Exhibits

is hereby supplemented by adding the following exhibits

Item 7 is hereby supplemented by adding the following exhibits: Exhibit No. Name 1. Kellner Group Press Release, dated January 3, 2024 2. Amendment to Group Agreement, dated January 3, 2024

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: January 3, 2024 TODD DEUTSCH By: /s/ Todd Deutsch TED D. KELLNER By: /s/ Ted D. Kellner

View Full Filing

View this SC 13D/A filing on SEC EDGAR